Paydirt
KB
Insider

Kenneth Bate

Director

Kenneth Bate (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Madrigal Pharmaceuticals, Inc. (MDGL). The largest single filing was $8.0M of MDGL (16,545 sh across 10 lots, as filed), executed Nov 5 2025.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$8.0M
shares × price, as filed
Last traded
Nov 5 2025
Filed Nov 7 2025

Median ADV $194.4M across their filed names

Open performance→
Volume by month
$8.0M$4.0M$0Oct 2024Apr 2025Oct 2025Apr 2026Feb 2025 · sells $6.9MAug 2025 · sells $3.7MNov 2025 · sells $8.0M
Buys $0 Sells $18.6M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names
MDGL Madrigal Pharmaceuticals, Inc. MDGL · 0 buys · 3 sells 3 filings
Recent filings
MDGLSALE Madrigal Pharmaceuticals, Inc. View filing → $8.0M
16,545 sh across 10 lots
Exec Nov 5 2025
Filed Nov 7 2025 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. View filing → $3.7M
10,000 sh across 6 lots
Exec Aug 15 2025
Filed Aug 15 2025 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. View filing → $6.9M
19,446 sh across 6 lots
Exec Feb 27 2025
Filed Feb 28 2025 · 5:30 PM ET